Acceleron Pharma (XLRN)

Acceleron Pharma (XLRN) – Hot FDA News

Jun 24, 2020 03:15 PM Acceleron Pharma (XLRN) Presents Topline Results of PULSAR Phase 2 Trial of Sotatercept in Patients with PAH
Mar 9, 2020 04:25 PM Acceleron Pharma (XLRN) to Discontinuing Development of ACE-083 After Phase 2 Trial in Patients with Charcot-Marie-Tooth Disease Fails
Jan 27, 2020 04:02 PM
Dec 6, 2019 12:07 PM
Sep 16, 2019 04:31 PM
Apr 4, 2019 04:07 PM
Jul 9, 2018 04:53 PM
Dec 11, 2017 05:48 AM
Jun 23, 2017 05:40 AM
Jun 23, 2017 05:40 AM
Jun 12, 2017 04:31 PM
Jun 1, 2017 07:38 AM